| Literature DB >> 22082641 |
Abstract
Although FDG PET and PET/CT have a well established role in the management of most cancer patients, they also have some limitations. For the last 15-20 years a growing number of non-FDG PET tracers have been used in research. Many of these new PET tracers are being investigated for the non-invasive assessment of different biologic functions in cancer cells. This unique information should contribute to making personalized cancer therapy a reality. This paper reviews the non-FDG PET tracers that are most likely to find clinical application, some of them in the near future.Entities:
Mesh：
Substances：
Year: 2011 PMID： 22082641 DOI： 10.1007/s12094-011-0733-7
Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.405